Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 17.

Sekaggya-Wiltshire, C; von Braun, A; Scherrer, A U; Manabe, Y C; Buzibye, A; Muller, D; Ledergerber, B; Gutteck, U; Corti, N; Kambugu, A; Byakika-Kibwika, P; Lamorde, M; Castelnuovo, B; Fehr, J; Kamya, M R (2017). Anti-TB drug concentrations and drug-associated toxicities among TB/HIV-coinfected patients. Journal of Antimicrobial Chemotherapy, 72(4):1172-1177.

Weiler, S; Corti, N (2014). Antibiotikatherapie: Wirkung und Resistenz. Medizinische Klinik - Intensivmedizin und Notfallmedizin, 109(3):167-174.

Weiler, S; Aellig, N; Fauchère, I; Jetter, A; Corti, N (2014). Treatment of gout in a renal transplant patient leading to severe thrombocytopenia. Journal of Clinical Pharmacy and Therapeutics, 39(5):571-572.

Preiswerk, B; Rudiger, A; Fehr, J; Corti, N (2013). Experience with daptomycin daily dosing in ICU patients undergoing continuous renal replacement therapy. Infection, 41(2):553-557.

Achermann, Y; Frauenfelder, T; Obrist, S; Zaugg, K; Corti, N; Günthard, H F (2012). A rare but severe pulmonary side effect of cetuximab in two patients. BMJ Case Reports:5 pages.

Corti, N; Taegtmeyer, A B (2012). Alle Medikamente zum Frühstück? - Einfluss der Nahrung auf die Medikamentenwirkung. Praxis, 101(13):849-55.

Taegtmeyer, A B; Curkovic, I; Corti, N; Rosen, C; Egbring, M; Russmann, S; Gantenbein, A R; Weller, M; Kullak-Ublick, G A (2012). Drug-related problems and factors influencing acceptance of clinical pharmacologists` alerts in a large cohort of neurology inpatients. Swiss Medical Weekly, 142:w13615.

Corti, N (2012). Intensivmedizinische Arzneitherapie. In: Kullak-Ublick, G A; Siepmann, T; Kirch, W. Arzneimitteltherapie: Wirksamkeit - Sicherheit - Praktische Anwendung. Stuttgart: Thieme, 359-371.

Rudiger, A; Rentsch, K; Maggiorini, M; Corti, N (2011). Daptomycin pharmacokinetics in critically ill patients undergoing continuous renal replacement therapy. Critical Care Medicine, 39(5):1243-1244.

Taegtmeyer, A B; Müller, V; Kovari, H; Kullak-Ublick, G A; Corti, N (2011). Effect of continuous venovenous hemodiafiltration on darunavir and raltegravir exposure after administration via a gastroduodenal tube. AIDS, 25(10):1339-1341.

Taegtmeyer, A B; Curkovic, I; Rufibach, K; Corti, N; Battegay, E; Kullak-Ublick, G A (2011). Electronic prescribing increases uptake of clinical pharmacologists' recommendations in the hospital setting. British Journal of Clinical Pharmacology, 72(6):958-964.

Corti, N; Grimm, V; Kullak-Ublick, G A (2010). Polymedikation und Wechselwirkungen: Medikamente bei älteren Patienten richtig dosieren. Zahnarzt Praxis, (2):1-6.

Curkovic, I; Lüthi, B; Franzen, D; Ceschi, A; Rudiger, A; Corti, N (2010). Trimethoprim/Sulfamethoxazole pharmacokinetics in two patients undergoing continuous venovenous hemodiafiltration. Annals of Pharmacotherapy, 44(10):1669-1672.

Corti, N; Heck, A; Rentsch, K; Zingg, W; Jetter, A; Stieger, B; Pauli-Magnus, C (2009). Effect of ritonavir on the pharmacokinetics of the benzimidazoles albendazole and mebendazole: an interaction study in healthy volunteers. European Journal of Clinical Pharmacology, 65(10):999-1006.

Serra, A L; Braun, S C; Starke, A; Savoca, R; Hersberger, M; Russmann, S; Corti, N; Wüthrich, R P (2008). Pharmacokinetics and pharmacodynamics of cinacalcet in patients with hyperparathyroidism after renal transplantation. American Journal of Transplantation, 8(4):803-810.

Corti, N; Kullak-Ublick, G A (2007). Pharmacogenetics. In: Blum, H E; Cox, D W; Häussinger, D; Janssen, P L M; Kullak-Ublick, G A. Genetics in Liver Diseases. Dordrecht (NL): Springer, 3-7.

Franzen, D; Burkhard, J; Corti, N; Schüpbach, D; Fontanel, D; Stäubli, M (2006). Malignes neuroleptisches Syndrom nach 30-jähriger Behandlung mit Clozapin: Eine seltene Differenzialdiagnose auf der Intensivstation. Anästhesiol Intensivmed Notfallmed Schmerzther, 41(2):125-127.

This list was generated on Mon Dec 18 14:10:29 2017 CET.